Clinical Trials Browser

For Patients With Colorectal Cancer Liver Metastases Who Were Not Able to Curative Surgical Resection.Focused on the Treatment Effect With the Quintuple Method

NCT05480280 2023-02-28

FIND

Phase 2 Unknown

18 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT05732493 2023-02-17

TORCH-C

Phase 2 Unknown

120 enrolled

Gastrointestinal

Locally Advanced Colon Cancer

NCT04984980 2023-01-26

Combination of Gemcitabine, Oxaliplatin, Sintilimab and Bevacizumab in Unresectable Biliary Tract Cancer

Phase 2 Unknown

37 enrolled

Gastrointestinal

Biliary Tract Carcinoma

NCT05617430 2022-11-15

Combination Therapy of HAIC, Sintilimab and Bevacizumab for Advanced Hepatocellular Carcinoma

Phase 2 Unknown

43 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

NCT05594381 2022-10-26

A Biomarker Study for Predicting the Efficacy of Neoadjuvant Sintilimab Plus SOX for Gastric Adenocarcinoma.

Phase 2 Unknown

90 enrolled

Gastrointestinal

Stomach Neoplasms

NCT05350943 2022-10-18

HAIC Combined With Toripalimab and Donafenib for Advanced BTC

Phase 2 Unknown

70 enrolled

Gastrointestinal

Biliary Tract Adenocarcinoma

NCT05545436 2022-09-22

Carrelizumab (PD-1) Combined With Chemotherapy in Neoadjuvant Treatment of Locally Advanced Gastric Cancer

Phase 2 Unknown

34 enrolled

Gastrointestinal

Locally Advanced Gastric Cancer

NCT03487016 2022-09-08

FOOTPATH

Phase 2 Unknown

270 enrolled

Gastrointestinal

Neoplasm Metastasis, Pancreatic Neoplasms

NCT05493332 2022-08-18

HAIC Combined With Donafenib Tosilate and Toripalimab for Unresectable HCC

Phase 2 Unknown

93 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

NCT01871571 2022-08-09

Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin Before Surgery in Treating Patients With Stage II-III Rectal Cancer

Phase 2 Unknown

17 enrolled

Gastrointestinal

Rectal Neoplasms

NCT05448183 2022-07-07

An Observational Real World Study on the Efficacy and Safety of Toripalimab Injection Combined With TACE in the Treatment of Extrahepatic Cholangiocarcinoma

Phase 2 Unknown

45 enrolled

Gastrointestinal

Cholangiocarcinoma

NCT05346874 2022-05-26

Neoadjuvant TACiE in Locally Advanced Gastric Cancer

Phase 2 Unknown

37 enrolled

Gastrointestinal

Stomach Neoplasms

NCT05216237 2022-04-11

A Study to Evaluate the Efficacy and Safety of Sintilimab Plus Apatinib and Chemotherapy in Patients With HER-2 Negative Microsatellite Stability (MSS) Advanced or Metastatic Gastric (GC) or Gastroesophageal Junction (GEJ) Cancer

Phase 2 Unknown

31 enrolled

Gastrointestinal

Stomach Neoplasms

NCT05218148 2022-04-06

SOX Combined With Sintilimab and Trastuzumab Versus SOX Regimen in the Perioperative Treatment of HER2-positive Locally Advanced Gastric Adenocarcinoma

Phase 2 Unknown

44 enrolled

GastrointestinalOther solid neoplasm

HER2-positive

NCT05291052 2022-03-22

Tisleizumab Combined With Lenvatinib and XELOX Regimen (Oxaliplatin Combined With Capecitabine) in the First-line Treatment of Advanced and Unresectable Biliary Tract Tumors

Phase 2 Unknown

20 enrolled

Gastrointestinal

Biliary Tract Tumor

NCT04119622 2022-03-11

Toripalimab Combined With Chemotherapy as Neoadjuvant Treatment of Gastric Cancer

Phase 2 Unknown

30 enrolled

Gastrointestinal

Stomach Neoplasms

NCT05186558 2022-03-07

Penpulimab Plus R2-GemOx Regimen in Relapsed or Refractory DLBCL

Phase 2 Unknown

54 enrolled

Lymphoid

Neoplasms by Histologic Type, Lymphoma, Large B-Cell, Diffuse

NCT05254899 2022-02-24

Anti-PD-1 Antibody and P-GEMOX Chemotherapy Combined With Radiotherapy in High-risk Early-Stage ENKTL

Phase 2 Unknown

54 enrolled

Lymphoid

Lymphoma, Extranodal NK-T-Cell

Clinical Trials

NALIRIFOX in Combination With Camrelizumab for BRPC: a Prospective, Exploratory Study

Peri-operative SLOG for Localized Pancreatic Cancer

IMAGINE

Fruquintinib Combined With Tislelizumab and HAIC in Patients With Advanced Colorectal Liver Metastases Cancer Who Failed Standard Therapy

HOLIPANC

Phase II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab in Advanced Gastric Cancer

FOLFOX-6 Induction Chemotherapy Followed by Esophagectomy and Post-operative Chemoradiotherapy in Patients With Esophageal Adenocarcinoma

Envafolimab Combined With Chemotherapy in Metastatic or Recurrent Gastric Adenocarcinoma

NIVOFGFR2

LARCT-US

ALTER-G-001

LOTS

Cadonilimab Plus FOLFOXIRI and Bevacizumab as First Line Therapy for Metastatic MSS Colorectal Cancer

AIO-KRK-0116

RAIC

INTERACT-II

POCHI

A Trial of Conversion Treatment of HAIC Combined With Camrelizumab and Apatinib for Unresected Hepatocellular Carcinoma

Sintilimab Combined With Modified FLOT Regimen in the Treatment of Metastatic Gastric Cancer

Cadonilimab Combined With CapeOX Regimen in Perioperative Treatment of Resectable Locally Advanced Gastric Cancer

Efficacy of Perioperative Chemotherapy Plus PD-1 Antibody in the Locally Advanced Gastric Cancer

FOLFOXIRI Plus Panitumumab in Metastatic RAS Wild-type, Left-sided Colorectal Cancer

To Evaluate the Efficacy and Safety of Cadonilimab With SOX as Neoadjuvant Therapy for Resectable Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma.

Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery

QL1706 Monotherapy or in Combination With Bevacizumab and XELOX as First-line Treatment of Unresectable Advanced or Metastatic CRC

Induction Chemotherapy Followed by Short Course Radiotherapy in Rectal Cancer

Efficacy and Safety of Tirelizumab Plus Chemotherapy Versus Chemotherapy Alone in Patients With Lymph Node Positive Gastric Cancer After Surgery

Study of Perioperative Chemotherapy Combined With Tislelizumab and Trastuzumab in the Treatment of GC/EGC

XELOX Combined With Cadonilimab Versus XELOX as Neoadjuvant Treatment for Locally Advanced, pMMR Rectal Cancer

Nab-paclitaxel Combined With Oxaliplatin and S-1 for Perioperative Treatment of Advanced Gastric Cancer

HIPEC

Quintuple Method for Treatment of Multiple Refractory Colorectal Liver Metastases

FIND

TORCH-C

Combination of Gemcitabine, Oxaliplatin, Sintilimab and Bevacizumab in Unresectable Biliary Tract Cancer

Combination Therapy of HAIC, Sintilimab and Bevacizumab for Advanced Hepatocellular Carcinoma

A Biomarker Study for Predicting the Efficacy of Neoadjuvant Sintilimab Plus SOX for Gastric Adenocarcinoma.

HAIC Combined With Toripalimab and Donafenib for Advanced BTC

Carrelizumab (PD-1) Combined With Chemotherapy in Neoadjuvant Treatment of Locally Advanced Gastric Cancer

FOOTPATH

HAIC Combined With Donafenib Tosilate and Toripalimab for Unresectable HCC

Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin Before Surgery in Treating Patients With Stage II-III Rectal Cancer

An Observational Real World Study on the Efficacy and Safety of Toripalimab Injection Combined With TACE in the Treatment of Extrahepatic Cholangiocarcinoma

Neoadjuvant TACiE in Locally Advanced Gastric Cancer

A Study to Evaluate the Efficacy and Safety of Sintilimab Plus Apatinib and Chemotherapy in Patients With HER-2 Negative Microsatellite Stability (MSS) Advanced or Metastatic Gastric (GC) or Gastroesophageal Junction (GEJ) Cancer

SOX Combined With Sintilimab and Trastuzumab Versus SOX Regimen in the Perioperative Treatment of HER2-positive Locally Advanced Gastric Adenocarcinoma

Tisleizumab Combined With Lenvatinib and XELOX Regimen (Oxaliplatin Combined With Capecitabine) in the First-line Treatment of Advanced and Unresectable Biliary Tract Tumors

Toripalimab Combined With Chemotherapy as Neoadjuvant Treatment of Gastric Cancer

Penpulimab Plus R2-GemOx Regimen in Relapsed or Refractory DLBCL

Anti-PD-1 Antibody and P-GEMOX Chemotherapy Combined With Radiotherapy in High-risk Early-Stage ENKTL